The Molecular Basis of Oligomeric Organization of the Human M3 Muscarinic Acetylcholine Receptor

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Pharmacology

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/mol.114.096925PMID 25769304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coupling of G Proteins to Reconstituted Monomers and Tetramers of the M2 Muscarinic Receptor*

  2014influential reference
• Structure of the human P2Y12 receptor in complex with an antithrombotic drug

  2014cited by this paper
• Targeting opioid receptors with pharmacological chaperones.

  2014cited by this paper
• Structural and biophysical characterisation of G protein-coupled receptor ligand binding using resonance energy transfer and fluorescent labelling techniques.

  2014cited by this paper
• Pharmacological chaperoning: a primer on mechanism and pharmacology.

  2014cited by this paper
• G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives

  2014cited by this paper
• Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator

  2014cited by this paper
• Muscarinic acetylcholine receptors: novel opportunities for drug development

  2014cited by this paper
• Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells.

  2013cited by this paper
• Abundance, distribution, mobility and oligomeric state of M2 muscarinic acetylcholine receptors in live cardiac muscle

  2013cited by this paper
• The muscarinic M3 acetylcholine receptor exists as two differently sized complexes at the plasma membrane.

  2013influential reference
• Serial Femtosecond Crystallography of G Protein–Coupled Receptors

  2013cited by this paper
• Crystal Structure of Oligomeric β1-Adrenergic G Protein- Coupled Receptors in Ligand-Free Basal State

  2013cited by this paper
• SNAP-tag technology: a general introduction.

  2013cited by this paper
• The Prevalence, Maintenance, and Relevance of G Protein–Coupled Receptor Oligomerization

  2013influential reference
• Mapping the functional binding sites of cholesterol in β2-adrenergic receptor by long-time molecular dynamics simulations.

  2013cited by this paper
• Structural Features for Functional Selectivity at Serotonin Receptors

  2013cited by this paper
• Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren’s syndrome

  2013cited by this paper
• Faculty Opinions recommendation of Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer.

  2013cited by this paper
• Intramolecular Fluorescence Resonance Energy Transfer (FRET) Sensors of the Orexin OX1 and OX2 Receptors Identify Slow Kinetics of Agonist Activation*

  2012influential reference
• Structure of the human kappa opioid receptor in complex with JDTic

  2012cited by this paper
• Crystal structure of the μ-opioid receptor bound to a morphinan antagonist

  2012cited by this paper
• Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor

  2012influential reference
• Structural aspects of M3 muscarinic acetylcholine receptor dimer formation and activation

  2012cited by this paper
• Critical metabolic roles of β-cell M3 muscarinic acetylcholine receptors.

  2012cited by this paper
• Structure of the human k-opioid receptor in complex with JDTic

  2012cited by this paper
• The role of cholesterol on the activity and stability of neurotensin receptor 1.

  2012cited by this paper
• Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling

  2012cited by this paper
• Muscarinic agonists and antagonists: effects on gastrointestinal function.

  2012cited by this paper
• Rhodopsin forms a dimer with cytoplasmic helix 8 contacts in native membranes.

  2012influential reference
• Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target.

  2012cited by this paper
• Crystal Structure of the β2Adrenergic Receptor-Gs protein complex

  2011cited by this paper
• Structural Basis of M3 Muscarinic Receptor Dimer/Oligomer Formation*

  2011influential reference
• Specific ligands as pharmacological chaperones: The transport of misfolded G‐protein coupled receptors to the cell surface

  2010cited by this paper
• Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors

  2010cited by this paper
• Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules

  2010cited by this paper
• Dimerization in GPCR mobility and signaling.

  2010cited by this paper
• Ligand Regulation of the Quaternary Organization of Cell Surface M3 Muscarinic Acetylcholine Receptors Analyzed by Fluorescence Resonance Energy Transfer (FRET) Imaging and Homogeneous Time-resolved FRET*

  2010cited by this paper
• THEMED ISSUE: GPCR REVIEW G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function

  2009cited by this paper
• Enhancement of the surface expression of G protein-coupled receptors.

  2009cited by this paper
• G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats.

  2009cited by this paper
• Functional Rescue of β1‐Adrenoceptor Dimerization and Trafficking by Pharmacological Chaperones

  2009cited by this paper
• Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer

  2009cited by this paper
• The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist

  2008cited by this paper
• GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.

  2008cited by this paper
• Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective α1b-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers

  2008cited by this paper
• High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

  2007influential reference
• The α1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function

  2007cited by this paper
• Opioid Receptor Pharmacological Chaperones Act by Binding and Stabilizing Newly Synthesized Receptors in the Endoplasmic Reticulum*

  2007cited by this paper
• Recovery of oligomers and cooperativity when monomers of the M2 muscarinic cholinergic receptor are reconstituted into phospholipid vesicles.

  2007cited by this paper
• Quantitative Analysis of Muscarinic Acetylcholine Receptor Homo- and Heterodimerization in Live Cells

  2006cited by this paper
• The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities*

  2005cited by this paper
• Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation.

  2005cited by this paper
• G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology

  2004cited by this paper
• Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting*

  2004cited by this paper
• The PyMOL Molecular Graphics System

  2002cited by this paper
• Cooperativity and oligomeric status of cardiac muscarinic cholinergic receptors.

  2002cited by this paper
• Comparative protein structure modeling of genes and genomes.

  2000cited by this paper
• Receptors as Kissing Cousins

  2000cited by this paper
• Neurobiology. Receptors as kissing cousins.

  2000cited by this paper
• Molecular biology of muscarinic acetylcholine receptors.

  1996cited by this paper
• [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors

  1995cited by this paper

• Cholesterol differentially modulates the activity of opioid and muscarinic receptors via a common binding site

  2025cites this paper
• Genetic variants of accessory proteins and G proteins in human genetic disease

  2025cites this paper
• Allosteric Sites and Allosteric Regulators of G Protein-Coupled Receptors: Gray Cardinals of Signal Transduction

  2023cites this paper
• A critical re-evaluation of the slope factor of the operational model of agonism: When to exponentiate operational efficacy

  2023cites this paper
• Insights into the operational model of agonism of receptor dimers

  2022cites this paper
• Neuroactive steroids, WIN-compounds and cholesterol share a common binding site on muscarinic acetylcholine receptors.

  2021cites this paper
• Allosteric Modulation of GPCRs of Class A by Cholesterol

  2021cites this paper
• The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?

  2019cites this paper
• GPCR homo-oligomerization

  2019cites this paper
• The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome.

  2019cites this paper
• Effect of the Organization of Rhodopsin on the Association between Transducin and a Photoactivated Receptor.

  2018cites this paper
• Role of membrane cholesterol in differential sensitivity of muscarinic receptor subtypes to persistently bound xanomeline

  2018cites this paper
• A Molecular Basis for Selective Antagonist Destabilization of Dopamine D3 Receptor Quaternary Organization

  2017cites this paper
• Spatial Intensity Distribution Analysis: Studies of G Protein-Coupled Receptor Oligomerisation

  2017cites this paper
• Muscarinic receptor oligomerization

  2017influential citation
• The Use of Spatial Intensity Distribution Analysis to Examine G Protein-Coupled Receptor Oligomerization

  2017cites this paper
• Dynamic Regulation of Quaternary Organization of the M1 Muscarinic Receptor by Subtype-selective Antagonist Drugs*

  2016cites this paper
• Single-molecule resolution of G protein-coupled receptor (GPCR) complexes.

  2016cites this paper
• Protease-activated receptors in hemostasis.

  2016cites this paper
• Regulation of Oligomeric Organization of the Serotonin 5-Hydroxytryptamine 2C (5-HT2C) Receptor Observed by Spatial Intensity Distribution Analysis

  2015cites this paper
• Analysis of Human Dopamine D3 Receptor Quaternary Structure

  2015cites this paper
• Approaches to Characterize and Quantify Oligomerization of GPCRs.

  2015cites this paper
• Cholesterol differentially modulates the activity of opioid and muscarinic receptors via common non-canonical binding site

  year unknowncites this paper